🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 8 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/02/2019 14,12 14,34 13,58 14,30 +1,27% 5,38% 2.111.700
31/01/2019 13,64 14,15 13,40 14,12 +3,67% 5,50% 1.383.000
30/01/2019 13,35 13,63 13,17 13,62 +3,18% 3,45% 1.503.300
29/01/2019 13,18 13,32 13,01 13,20 +0,15% 2,35% 1.106.400
28/01/2019 13,54 13,75 13,02 13,18 -3,94% 5,39% 1.166.700
25/01/2019 13,10 13,79 12,99 13,72 +5,13% 6,11% 2.469.600
24/01/2019 12,77 13,15 12,56 13,05 +1,87% 4,62% 1.469.600
23/01/2019 13,18 13,32 12,51 12,81 -2,21% 6,16% 1.478.100
22/01/2019 14,30 14,30 13,05 13,10 -9,78% 8,78% 2.092.800
18/01/2019 14,62 14,96 14,10 14,52 -0,75% 5,88% 1.530.000
17/01/2019 14,43 14,92 14,24 14,63 +0,83% 4,71% 956.800
16/01/2019 14,76 15,02 14,50 14,51 -1,02% 3,52% 954.300
15/01/2019 14,23 14,66 14,23 14,66 +3,09% 3,02% 1.085.900
14/01/2019 14,56 14,73 14,02 14,22 -4,37% 4,88% 1.359.800
11/01/2019 14,77 15,28 14,63 14,87 -0,87% 4,42% 1.261.000
10/01/2019 14,64 15,04 14,03 15,00 +1,63% 6,90% 1.109.000
09/01/2019 14,60 15,11 14,47 14,76 +1,79% 4,38% 3.072.500
08/01/2019 14,23 14,58 13,75 14,50 +2,76% 5,83% 2.059.600
07/01/2019 13,21 14,29 12,86 14,11 +7,06% 10,83% 1.976.600
04/01/2019 12,23 13,32 11,85 13,18 +9,38% 12,02% 2.659.200
03/01/2019 12,90 13,05 11,95 12,05 -8,16% 8,53% 2.203.200
02/01/2019 12,16 13,13 11,67 13,12 +5,64% 12,01% 1.895.100
31/12/2018 12,16 12,57 12,01 12,42 +4,02% 4,56% 1.678.400
28/12/2018 11,97 12,31 11,74 11,94 -0,25% 4,76% 1.600.300
27/12/2018 11,66 12,24 11,25 11,97 +0,08% 8,49% 1.968.700
26/12/2018 10,90 12,00 10,78 11,96 +11,36% 11,19% 2.537.700
24/12/2018 10,98 11,13 10,41 10,74 -4,19% 6,56% 1.872.600
21/12/2018 12,91 12,91 11,14 11,21 -12,90% 13,71% 3.493.400
20/12/2018 13,35 13,70 12,52 12,87 -4,31% 8,84% 2.221.200
19/12/2018 13,71 14,37 13,26 13,45 -2,04% 8,10% 2.129.400